ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 282,22
-1,51%
Dow Jones
42 732,13
0,80%
DAX
19 906,08
-0,49%
Brent Oil
76,355
-0,20%
Bitcoin
98 956,97
0,66%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ

  6. IO Biotech Inc (IOBT) Cours

IO Biotech Inc

IO Biotech Inc (IOBT)

NASDAQ
0,9352
0,0094
(1,02%)
Fermé 06 Janvier 10:00PM
Retardé de 15 minutes
0,9875
0,0523
(5,59%)
Après les heures de négociation: 11:52PM
Retardé de 15 minutes

Outils de qualité professionnelle, pour des investisseurs individuels.

Premium

Statistiques et détails clés

Dernier
0,9875
Prix Achat
0,2101
Prix Vente
1,70
Volume échangé
174 204
0,90 Fourchette du Jour 0,9918
0,66 Plage de 52 semaines 2,098
Cap du marché
65,057M
Clôture Veille
0,9258
Ouverture
0,92
Dernière Transaction
1
@
0.95
Dernière heure de transaction
Volume financier
US$ 161 103
VWAP
0,924797
Volume moyen (3 m)
385 070
Actions en circulation
65 880 914
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-0,72
Bénéfice par action (BPA)
-1,31
Chiffre d'affairess
-
Bénéfice net
-86,08M

À propos de IO Biotech Inc

IO Biotech Inc is a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer therapies based on T-win technology platform. The product candidates are designed to induce the immune system to simultaneously target and disrupt multiple pathways that regulate tumor-induced imm... IO Biotech Inc is a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer therapies based on T-win technology platform. The product candidates are designed to induce the immune system to simultaneously target and disrupt multiple pathways that regulate tumor-induced immunosuppression. Show more

Secteur
Pharmaceutical Preparations
Industrie
Pharmaceutical Preparations
Site Web
www.iobiotech.com
Siège social
Wilmington, Delaware, USA
Fondé
-
IO Biotech Inc est coté dans le secteur Pharmaceutical Preparations de la NASDAQ avec le ticker IOBT. Le dernier cours de clôture d'IO Biotech était de US$0,93. Au cours de la dernière année, les actions de IO Biotech ont été négociées dans une fourchette de prix de US$ 0,66 à US$ 2,098.

IO Biotech compte actuellement 65 880 914 actions en circulation. La capitalisation boursière d'IO Biotech est de US$60,99 million. IO Biotech a un ratio cours/bénéfice (ratio PE) de -0.72.

IOBT Dernières nouvelles

Plus de nouvelles

Form 8-K - Current report

27 Décembre 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

26 Décembre 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

24 Décembre 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

24 Décembre 2024
Edgar (US Regulatory)

Form 8-K - Current report

20 Décembre 2024
Edgar (US Regulatory)

IO Biotech secures up to €57.5 million in debt financing from the European Investment Bank

Funds expected to be used to advance IO Biotech’s immune-modulating therapeutic cancer vaccines, including potential BLA submission for IO102-IO103 in 2025Commitment is part of the European...

20 Décembre 2024
GlobeNewswire Inc.

Form 8-K - Current report

16 Décembre 2024
Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

12 Novembre 2024
Edgar (US Regulatory)

Form 8-K - Current report

12 Novembre 2024
Edgar (US Regulatory)

IO Biotech Reports Third Quarter 2024 Financial Results and Provides Business Highlights

Pivotal Phase 3 trial (IOB-013/KN-D18) evaluating off-the-shelf therapeutic cancer vaccine IO102-IO103 in combination with Merck’s anti-PD-1 therapy KEYTRUDA® (pembrolizumab) in patients with...

12 Novembre 2024
GlobeNewswire Inc.
PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
10.0376353.96214198860.9498651.060.882588160.95638289CS
40.157618.99023978790.82991.060.72772733520.8619269CS
12-0.0625-5.952380952381.051.360.663850700.8713936CS
26-0.1825-15.59829059831.171.730.663950061.01017251CS
52-0.9325-48.56770833331.922.0980.662601841.13746768CS
156-5.5825-84.96955859976.579.770.661443461.65746019CS
260-15.0125-93.8281251617.880.661475842.3281573CS

IOBT - Frequently Asked Questions (FAQ)

What is the current IO Biotech share price?
The current share price of IO Biotech is US$ 0,9875
How many IO Biotech shares are in issue?
IO Biotech has 65 880 914 shares in issue
What is the market cap of IO Biotech?
The market capitalisation of IO Biotech is USD 60,99M
What is the 1 year trading range for IO Biotech share price?
IO Biotech has traded in the range of US$ 0,66 to US$ 2,098 during the past year
What is the PE ratio of IO Biotech?
The price to earnings ratio of IO Biotech is -0,72
What is the reporting currency for IO Biotech?
IO Biotech reports financial results in USD
What is the latest annual profit for IO Biotech?
The latest annual profit of IO Biotech is USD -86,08M
What is the registered address of IO Biotech?
The registered address for IO Biotech is CORPORATION TRUST CENTER, 1209 ORANGE ST, WILMINGTON, DELAWARE, 19801
What is the IO Biotech website address?
The website address for IO Biotech is www.iobiotech.com
Which industry sector does IO Biotech operate in?
IO Biotech operates in the PHARMACEUTICAL PREPARATIONS sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
FCUVFocus Universal Inc
US$ 0,9499
(174,93%)
260,93M
NITON2OFF Inc
US$ 2,6306
(145,85%)
358,28M
CRNCCerence Inc
US$ 19,33
(143,76%)
161,8M
KITTNauticus Robotics Inc
US$ 3,8249
(140,56%)
104,8M
ACONAclarion Inc
US$ 0,2984
(110,14%)
305,64M
HWHHWH International Inc
US$ 0,4621
(-28,80%)
7,43M
SMSTDefiance Daily Target 2x Short MSTR ETF
US$ 5,69
(-26,30%)
24,77M
RAINRain Enhancement Technologies Holdco Inc
US$ 5,59
(-23,42%)
161,15k
PTLEPTL Ltd
US$ 9,35
(-23,30%)
1,04M
NXUNXU Inc
US$ 0,725868
(-22,78%)
7,59M
NITON2OFF Inc
US$ 2,6306
(145,85%)
358,28M
TGLTreasure Global Inc
US$ 0,382
(101,58%)
337,5M
ACONAclarion Inc
US$ 0,2984
(110,14%)
305,64M
FCUVFocus Universal Inc
US$ 0,9499
(174,93%)
260,93M
NVDANVIDIA Corporation
US$ 144,47
(4,45%)
230,01M

Forums

Afficher les forums
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

NASDAQ
IOBT
IO Biotech
LSE
0A17
Vanguard Small Cap Value...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2025 ADVFN PLC - Tous droits réservés